Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    0(0%)
    Results Posted
    100%(4 trials)

    Phase Distribution

    Not Applicable
    4
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution4 total trials
    N/ANon-phased studies
    4(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(4)

    Detailed Status

    Completed4

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A4 (100.0%)

    Trials by Status

    completed4100%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completednot_applicable

    Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

    NCT03226769
    completednot_applicable

    Effect of TrueTear Corneal Surface Imaging

    NCT03637348
    completednot_applicable

    Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

    NCT03325673
    completednot_applicable

    Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

    NCT03097614

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT03226769Not Applicable

    Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

    Completed
    NCT03637348Not Applicable

    Effect of TrueTear Corneal Surface Imaging

    Completed
    NCT03325673Not Applicable

    Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

    Completed
    NCT03097614Not Applicable

    Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    4